We caught up with Charles C. Wykoff, M.D., Ph.D., after this year’s American Society of Retina Specialists (ASRS) meeting , which was held in Long Beach, California, July 30 through Aug. 2. Wykoff, a retina specialist and ophthalmologist with Retina Consultants of Texas, is a leading retina researcher and a leader in ASRS who is currently the organization’s treasurer and chair of its council on finance. We asked Wykoff for his take on this year’s meeting and about his presentation on the COAST trial that was halted earlier this year. You can check out MHE ’s coverage of the ASRS here .

What was one of the main takeaways from the ASRS 2025 meeting?

There continues to be an unmet need for new therapies for geographic atrophy [GA], and there is interest — and even maybe excitement — i

See Full Page